4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000102
Director sold 1,535 shares at $1,040.00 ($1,596,400)
- Director acquired 1,535 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BROWN MICHAEL S · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,535 | $625.60 | $960,296 | 2,917 | D |
| 2024-06-14 | Sale : show line 2 in the form 10b5-1 | −1,535 | $1,040.00 | $1,596,400 | 1,382 | D |
| Open-market sales · 1,535 sh · avg $1,040.00 · $1,596,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-14 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,535 | 0 | D |
Loading xslF345X05/edgardoc.xml…